Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment of ulcerative colitis.

D Ludwig1, E F Stange

  • 1Department of Internal Medicine, University of Lübeck, Germany.

Hepato-Gastroenterology
|February 26, 2000
PubMed
Summary

New ulcerative colitis (UC) treatments include 5-aminosalicylates for mild/moderate cases and corticosteroids for severe disease. Novel options like E. coli Nissle aid relapse prevention in UC management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Erratum to: New treatment targets for inflammatory bowel disease?]

Innere Medizin (Heidelberg, Germany)·2025
Same author

[New treatment targets for inflammatory bowel disease?]

Innere Medizin (Heidelberg, Germany)·2024
Same author

Species-wide quantitative transcriptomes and proteomes reveal distinct genetic control of gene expression variation in yeast.

bioRxiv : the preprint server for biology·2023
Same author

Laboratory biomarkers associated with COVID-19 severity and management.

Clinical immunology (Orlando, Fla.)·2020
Same author

A novel cohorting and isolation strategy for suspected COVID-19 cases during a pandemic.

The Journal of hospital infection·2020
Same author

Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.

Proceedings of the National Academy of Sciences of the United States of America·2019

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pharmacology

Background:

  • Ulcerative colitis (UC) treatment standards have evolved.
  • This review addresses current evidence-based therapies and novel approaches for UC.

Purpose of the Study:

  • To update evidence-based therapies for various ulcerative colitis clinical situations.
  • To review novel treatment approaches for ulcerative colitis.

Main Methods:

  • Literature search of Medline and Cochrane database.
  • Handsearch of relevant papers and quoted literature.

Main Results:

  • 5-aminosalicylates are supported for mild/moderate distal and extensive UC.
  • Corticosteroids are indicated for severe UC; cyclosporine or colectomy for fulminant attacks.
  • Azathioprine may help chronic active UC; 5-aminosalicylates or E. coli Nissle for relapse prevention.

Conclusions:

  • Evidence-based trials guide individual ulcerative colitis treatment decisions.
  • Current standards support specific therapies based on UC severity and presentation.
  • Novel approaches like E. coli Nissle offer new avenues for UC relapse prevention.

Related Experiment Videos